7-26152649-G-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004289.7(NFE2L3):c.151G>T(p.Gly51Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000225 in 1,507,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G51V) has been classified as Uncertain significance.
Frequency
Consequence
NM_004289.7 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151940Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000384 AC: 4AN: 104102 AF XY: 0.0000338 show subpopulations
GnomAD4 exome AF: 0.00000885 AC: 12AN: 1355744Hom.: 0 Cov.: 31 AF XY: 0.00000746 AC XY: 5AN XY: 670248 show subpopulations
GnomAD4 genome AF: 0.000145 AC: 22AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74334 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.151G>T (p.G51C) alteration is located in exon 1 (coding exon 1) of the NFE2L3 gene. This alteration results from a G to T substitution at nucleotide position 151, causing the glycine (G) at amino acid position 51 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at